Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for AXSM

Stock Name	Axsome Therapeutics Inc
Ticker	AXSM(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05464T1043
LEI	549300EXGR0XLRJEIB95

Show aggregate AXSM holdings

News associated with AXSM

Peek Under The Hood: JHMM Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-19 08:11:32
Roger Jeffs Sells 13,464 Shares of Axsome Therapeutics (NASDAQ:AXSM) Stock: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Roger Jeffs sold 13,464 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $123.68, for a total value of $1,665,227.52. Following the completion of the sale, the director owned 57,510 shares in […] - 2025-09-04 05:23:00
Deutsche Bank AG Lowers Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Deutsche Bank AG reduced its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 21.2% during the first quarter, Holdings Channel reports. The institutional investor owned 94,980 shares of the company’s stock after selling 25,567 shares during the period. Deutsche Bank AG’s holdings in Axsome Therapeutics were worth $11,078,000 as of its […] - 2025-08-15 05:17:09
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $189.00 at Royal Bank Of Canada: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective increased by analysts at Royal Bank Of Canada from $184.00 to $189.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 83.03% from the […] - 2025-08-07 05:30:53
KLP Kapitalforvaltning AS Decreases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM): KLP Kapitalforvaltning AS reduced its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.8% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,200 shares of the company’s stock after selling 600 shares during the period. KLP Kapitalforvaltning AS’s holdings in Axsome Therapeutics were worth […] - 2025-07-29 05:28:50
Cerity Partners LLC Raises Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Cerity Partners LLC lifted its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 15.5% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 5,707 shares of the company’s stock after purchasing an additional 766 shares during the period. Cerity Partners LLC’s holdings in Axsome Therapeutics were worth $666,000 as of […] - 2025-07-25 04:50:58
12,745 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Acquired by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd purchased a new stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 12,745 shares of the company’s stock, valued at approximately $1,486,000. A number of other hedge funds have also recently made changes to their positions in AXSM. HighTower Advisors LLC […] - 2025-07-24 06:02:49
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by New York State Common Retirement Fund: New York State Common Retirement Fund raised its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 49.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 33,581 shares of the company’s stock after buying an additional 11,090 […] - 2025-07-22 07:13:06
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Bought by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC lifted its position in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,623 shares of the company’s stock after acquiring an additional 136 […] - 2025-07-17 05:39:38
D.A. Davidson & CO. Has $788,000 Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): D.A. Davidson & CO. reduced its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 17.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,755 shares of the company’s stock after selling 1,475 shares during the quarter. D.A. Davidson […] - 2025-07-10 05:31:08
Head-To-Head Review: Axsome Therapeutics (NASDAQ:AXSM) vs. Rosetta Genomics (OTCMKTS:ROSGQ): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Rosetta Genomics (OTCMKTS:ROSGQ – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Risk and Volatility Axsome Therapeutics has a beta […] - 2025-07-07 02:28:50
Janney Montgomery Scott LLC Has $1.74 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Janney Montgomery Scott LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 8.6% in the 1st quarter, HoldingsChannel reports. The fund owned 14,923 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Axsome Therapeutics were worth $1,740,000 at the end […] - 2025-06-27 04:26:52
AXSM Makes Notable Cross Below Critical Moving Average: In trading on Monday, shares of Axsome Therapeutics Inc (Symbol: AXSM) crossed below their 200 day moving average of $102.28, changing hands as low as $101.01 per share. Axsome Therapeutics Inc shares are currently trading down about 1.9% on the day. The chart below shows the - 2025-06-16 12:41:26
GAMMA Investing LLC Increases Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): GAMMA Investing LLC increased its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 38,571.9% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 22,043 shares of the company’s stock after buying an additional 21,986 shares during the quarter. GAMMA Investing […] - 2025-06-13 05:14:47
Rhumbline Advisers Grows Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Rhumbline Advisers boosted its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.9% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,760 shares of the company’s stock after acquiring an additional 3,515 shares during the quarter. Rhumbline Advisers’ holdings in Axsome Therapeutics […] - 2025-06-12 05:31:01
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM): Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $180.00 target price on the stock. HC Wainwright’s price target would suggest a potential upside of 66.54% from the stock’s previous close. Several other […] - 2025-06-12 02:18:55
Needham & Company LLC Cuts Axsome Therapeutics (NASDAQ:AXSM) Price Target to $150.00: Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective decreased by Needham & Company LLC from $153.00 to $150.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 36.48% from the […] - 2025-06-11 02:44:51
2 Soaring Stocks Wth More Upside Potential: Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies following significant runs. Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to Summit - 2025-06-05 04:19:00
Nuveen Asset Management LLC Increases Stock Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM): Nuveen Asset Management LLC raised its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 118.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 221,202 shares of the company’s stock after acquiring an additional 119,780 shares during the period. Nuveen Asset Management LLC’s holdings in Axsome Therapeutics were worth $18,716,000 as of its […] - 2025-05-25 06:03:20
Captrust Financial Advisors Sells 2,769 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Captrust Financial Advisors decreased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 48.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,953 shares of the company’s stock after selling 2,769 shares during the period. Captrust Financial Advisors’ holdings in Axsome Therapeutics […] - 2025-05-22 04:47:00
Comerica Bank Sells 3,570 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM): Comerica Bank trimmed its position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 32.6% during the 4th quarter, HoldingsChannel reports. The firm owned 7,374 shares of the company’s stock after selling 3,570 shares during the quarter. Comerica Bank’s holdings in Axsome Therapeutics were worth $624,000 at the end of the most recent reporting period. […] - 2025-05-15 04:52:49
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $162.00: Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price lifted by Robert W. Baird from $160.00 to $162.00 in a report released on Tuesday, Marketbeat reports. Robert W. Baird currently has an outperform rating on the stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reaffirmed a “buy” […] - 2025-05-09 03:56:43
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Purchased by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD raised its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 12.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 31,228 shares of the company’s stock after acquiring an additional 3,366 shares during the period. Price T Rowe Associates […] - 2025-05-07 05:50:49
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 5.6% After Earnings Beat: Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report)’s stock price was up 5.6% during trading on Monday following a better than expected earnings announcement. The stock traded as high as $117.60 and last traded at $118.54. Approximately 231,459 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 683,737 […] - 2025-05-07 02:24:42
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 10:32:49
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 08:45:35
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 06:31:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 03:51:04
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 02:59:18
Stocks Close Lower on US Trade Policy Uncertainty: The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.67%. June E-mini S&P futures (ESM25 ) are down -0.66%, and June E-mini Nasdaq futures... - 2025-05-06 01:28:32

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc AXSM holdings

Date	Number of AXSM Shares Held	Base Market Value of AXSM Shares	Local Market Value of AXSM Shares	Change in AXSM Shares Held	Change in AXSM Base Value	Current Price per AXSM Share Held	Previous Price per AXSM Share Held
2025-11-12 (Wednesday)	7,714	USD 1,086,594	USD 1,086,594	-25	USD 6,152	USD 140.86	USD 139.61
2025-11-11 (Tuesday)	7,739	USD 1,080,442	USD 1,080,442	0	USD 14,008	USD 139.61	USD 137.8
2025-11-10 (Monday)	7,739	USD 1,066,434	USD 1,066,434	0	USD -2,709	USD 137.8	USD 138.15
2025-11-07 (Friday)	7,739	USD 1,069,143	USD 1,069,143	0	USD -9,751	USD 138.15	USD 139.41
2025-11-06 (Thursday)	7,739	USD 1,078,894	USD 1,078,894	-25	USD 25,397	USD 139.41	USD 135.69
2025-11-05 (Wednesday)	7,764	USD 1,053,497	USD 1,053,497	-250	USD -27,832	USD 135.69	USD 134.93
2025-11-04 (Tuesday)	8,014	USD 1,081,329	USD 1,081,329	-50	USD -13,359	USD 134.93	USD 135.75
2025-11-03 (Monday)	8,064	USD 1,094,688	USD 1,094,688	-50	USD -621	USD 135.75	USD 134.99
2025-10-31 (Friday)	8,114	USD 1,095,309	USD 1,095,309	0	USD 14,930	USD 134.99	USD 133.15
2025-10-30 (Thursday)	8,114	USD 1,080,379	USD 1,080,379	0	USD -1,461	USD 133.15	USD 133.33
2025-10-29 (Wednesday)	8,114	USD 1,081,840	USD 1,081,840	0	USD -1,460	USD 133.33	USD 133.51
2025-10-28 (Tuesday)	8,114	USD 1,083,300	USD 1,083,300	75	USD 607	USD 133.51	USD 134.68
2025-10-27 (Monday)	8,039	USD 1,082,693	USD 1,082,693	0	USD 41,241	USD 134.68	USD 129.55

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AXSM by Blackrock for IE00B3VWM098

Show aggregate share trades of AXSM

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 SELL -25 144.150 139.700 140.145 USD -3,504 110.99 Loss of -729 on sale
2025-11-06 SELL -25 141.360 133.010 133.845 USD -3,346 110.42 Loss of -586 on sale
2025-11-05 SELL -250 135.800 131.680 132.092 USD -33,023 110.28 Loss of -5,452 on sale
2025-11-04 SELL -50 136.100 131.510 131.969 USD -6,598 110.16 Loss of -1,091 on sale
2025-11-03 SELL -50 137.700 123.500 124.920 USD -6,246 110.02 Loss of -745 on sale
2025-10-28 BUY 75 133.510 136.230 135.958 USD 10,197 109.51
2025-10-24 SELL -25 129.550 130.630 130.522 USD -3,263 109.26 Loss of -531 on sale
2025-10-15 BUY 150 129.580 130.350 130.273 USD 19,541 108.49
2025-10-02 BUY 25 119.940 120.800 120.714 USD 3,018 108.36
2025-09-30 BUY 50 121.450 121.470 121.468 USD 6,073 108.22
2025-09-11 BUY 100 122.960 124.510 124.355 USD 12,436 107.93
2025-08-21 SELL -25 117.140 117.290 117.275 USD -2,932 107.87 Loss of -235 on sale
2025-07-31 BUY 75 101.380 103.494 103.283 USD 7,746 107.86
2025-06-30 SELL -50 104.390 104.580 104.561 USD -5,228 107.98 Profit of 171 on sale
2025-06-25 SELL -25 103.700 104.740 104.636 USD -2,616 108.08 Profit of 86 on sale
2025-06-20 SELL -50 100.690 103.915 103.593 USD -5,180 108.21 Profit of 231 on sale
2025-05-30 BUY 1,235 105.160 105.550 105.511 USD 130,306 108.38
2025-05-23 BUY 21 105.070 105.410 105.376 USD 2,213 108.55
2025-05-19 SELL -21 108.300 109.145 109.060 USD -2,290 108.61 Loss of -9 on sale
2025-05-15 SELL -60 107.220 107.390 107.373 USD -6,442 108.64 Profit of 76 on sale
2025-05-12 SELL -21 110.160 110.953 110.874 USD -2,328 108.69 Loss of -46 on sale
2025-05-09 SELL -20 107.760 110.160 109.920 USD -2,198 108.70 Loss of -24 on sale
2025-04-30 SELL -21 112.290 113.000 112.929 USD -2,372 108.47 Loss of -94 on sale
2025-04-24 SELL -40 105.410 105.810 105.770 USD -4,231 108.52 Profit of 110 on sale
2025-04-17 SELL -20 104.460 105.660 105.540 USD -2,111 108.76 Profit of 64 on sale
2025-04-15 SELL -63 103.830 104.530 104.460 USD -6,581 108.86 Profit of 277 on sale
2025-04-14 SELL -60 103.530 104.220 104.151 USD -6,249 108.92 Profit of 286 on sale
2025-04-09 SELL -80 101.670 103.750 103.542 USD -8,283 109.27 Profit of 459 on sale
2025-04-07 SELL -147 98.500 102.200 101.830 USD -14,969 109.54 Profit of 1,133 on sale
2025-04-04 SELL -210 98.860 106.285 105.543 USD -22,164 109.66 Profit of 865 on sale
2025-03-31 BUY 21 116.630 117.780 117.665 USD 2,471 109.55
2025-03-19 SELL -42 125.900 126.220 126.188 USD -5,300 108.04 Loss of -762 on sale
2025-03-14 SELL -126 121.910 123.470 123.314 USD -15,538 107.36 Loss of -2,010 on sale
2025-03-13 SELL -40 121.650 122.860 122.739 USD -4,910 107.16 Loss of -623 on sale
2025-03-12 SELL -680 119.450 122.510 122.204 USD -83,099 106.98 Loss of -10,351 on sale
2025-03-07 SELL -40 122.170 124.960 124.681 USD -4,987 106.38 Loss of -732 on sale
2025-03-06 SELL -60 124.410 126.700 126.471 USD -7,588 106.11 Loss of -1,222 on sale
2025-03-03 SELL -20 127.150 130.110 129.814 USD -2,596 105.15 Loss of -493 on sale
2025-02-28 SELL -1,078 127.540 128.770 128.647 USD -138,681 104.78 Loss of -25,729 on sale
2025-02-26 SELL -23 128.330 130.949 130.687 USD -3,006 104.01 Loss of -613 on sale
2025-02-25 SELL -69 127.090 131.990 131.500 USD -9,074 103.62 Loss of -1,924 on sale
2025-02-18 BUY 115 128.090 130.148 129.942 USD 14,943 101.08
2025-02-13 BUY 23 131.680 132.135 132.089 USD 3,038 99.26
2025-02-12 BUY 23 131.550 133.100 132.945 USD 3,058 98.60
2025-02-11 BUY 69 132.200 134.185 133.986 USD 9,245 97.90
2025-02-06 BUY 207 109.500 114.061 113.605 USD 23,516 96.82
2025-01-27 BUY 23 102.690 105.638 105.343 USD 2,423 94.52
2024-12-30 BUY 115 84.780 84.980 84.960 USD 9,770 94.48
2024-12-06 BUY 92 100.100 100.240 100.226 USD 9,221 93.98
2024-12-05 BUY 23 98.350 99.495 99.381 USD 2,286 93.83
2024-12-04 BUY 115 99.540 102.420 102.132 USD 11,745 93.62
2024-11-29 BUY 115 98.220 100.990 100.713 USD 11,582 92.95
2024-11-27 BUY 92 99.650 100.480 100.397 USD 9,237 92.36
2024-11-26 BUY 23 97.030 99.000 98.803 USD 2,272 92.15
2024-11-21 BUY 115 98.190 99.350 99.234 USD 11,412 91.21
2024-11-20 BUY 69 94.600 96.920 96.688 USD 6,671 91.02
2024-11-18 BUY 276 92.450 95.000 94.745 USD 26,150 90.65
2024-11-12 BUY 184 99.490 101.505 101.303 USD 18,640 90.06
2024-11-08 BUY 115 90.070 91.370 91.240 USD 10,493 90.06
2024-11-07 BUY 345 90.700 92.549 92.364 USD 31,866 90.01
2024-11-06 BUY 46 90.970 93.000 92.797 USD 4,269 89.93
2024-10-31 BUY 23 89.030 90.200 90.083 USD 2,072 90.60
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	SELL	-25	144.150	139.700	140.145	USD -3,504	110.99 Loss of -729 on sale
2025-11-06	SELL	-25	141.360	133.010	133.845	USD -3,346	110.42 Loss of -586 on sale
2025-11-05	SELL	-250	135.800	131.680	132.092	USD -33,023	110.28 Loss of -5,452 on sale
2025-11-04	SELL	-50	136.100	131.510	131.969	USD -6,598	110.16 Loss of -1,091 on sale
2025-11-03	SELL	-50	137.700	123.500	124.920	USD -6,246	110.02 Loss of -745 on sale
2025-10-28	BUY	75	133.510	136.230	135.958	USD 10,197	109.51
2025-10-24	SELL	-25	129.550	130.630	130.522	USD -3,263	109.26 Loss of -531 on sale
2025-10-15	BUY	150	129.580	130.350	130.273	USD 19,541	108.49
2025-10-02	BUY	25	119.940	120.800	120.714	USD 3,018	108.36
2025-09-30	BUY	50	121.450	121.470	121.468	USD 6,073	108.22
2025-09-11	BUY	100	122.960	124.510	124.355	USD 12,436	107.93
2025-08-21	SELL	-25	117.140	117.290	117.275	USD -2,932	107.87 Loss of -235 on sale
2025-07-31	BUY	75	101.380	103.494	103.283	USD 7,746	107.86
2025-06-30	SELL	-50	104.390	104.580	104.561	USD -5,228	107.98 Profit of 171 on sale
2025-06-25	SELL	-25	103.700	104.740	104.636	USD -2,616	108.08 Profit of 86 on sale
2025-06-20	SELL	-50	100.690	103.915	103.593	USD -5,180	108.21 Profit of 231 on sale
2025-05-30	BUY	1,235	105.160	105.550	105.511	USD 130,306	108.38
2025-05-23	BUY	21	105.070	105.410	105.376	USD 2,213	108.55
2025-05-19	SELL	-21	108.300	109.145	109.060	USD -2,290	108.61 Loss of -9 on sale
2025-05-15	SELL	-60	107.220	107.390	107.373	USD -6,442	108.64 Profit of 76 on sale
2025-05-12	SELL	-21	110.160	110.953	110.874	USD -2,328	108.69 Loss of -46 on sale
2025-05-09	SELL	-20	107.760	110.160	109.920	USD -2,198	108.70 Loss of -24 on sale
2025-04-30	SELL	-21	112.290	113.000	112.929	USD -2,372	108.47 Loss of -94 on sale
2025-04-24	SELL	-40	105.410	105.810	105.770	USD -4,231	108.52 Profit of 110 on sale
2025-04-17	SELL	-20	104.460	105.660	105.540	USD -2,111	108.76 Profit of 64 on sale
2025-04-15	SELL	-63	103.830	104.530	104.460	USD -6,581	108.86 Profit of 277 on sale
2025-04-14	SELL	-60	103.530	104.220	104.151	USD -6,249	108.92 Profit of 286 on sale
2025-04-09	SELL	-80	101.670	103.750	103.542	USD -8,283	109.27 Profit of 459 on sale
2025-04-07	SELL	-147	98.500	102.200	101.830	USD -14,969	109.54 Profit of 1,133 on sale
2025-04-04	SELL	-210	98.860	106.285	105.543	USD -22,164	109.66 Profit of 865 on sale
2025-03-31	BUY	21	116.630	117.780	117.665	USD 2,471	109.55
2025-03-19	SELL	-42	125.900	126.220	126.188	USD -5,300	108.04 Loss of -762 on sale
2025-03-14	SELL	-126	121.910	123.470	123.314	USD -15,538	107.36 Loss of -2,010 on sale
2025-03-13	SELL	-40	121.650	122.860	122.739	USD -4,910	107.16 Loss of -623 on sale
2025-03-12	SELL	-680	119.450	122.510	122.204	USD -83,099	106.98 Loss of -10,351 on sale
2025-03-07	SELL	-40	122.170	124.960	124.681	USD -4,987	106.38 Loss of -732 on sale
2025-03-06	SELL	-60	124.410	126.700	126.471	USD -7,588	106.11 Loss of -1,222 on sale
2025-03-03	SELL	-20	127.150	130.110	129.814	USD -2,596	105.15 Loss of -493 on sale
2025-02-28	SELL	-1,078	127.540	128.770	128.647	USD -138,681	104.78 Loss of -25,729 on sale
2025-02-26	SELL	-23	128.330	130.949	130.687	USD -3,006	104.01 Loss of -613 on sale
2025-02-25	SELL	-69	127.090	131.990	131.500	USD -9,074	103.62 Loss of -1,924 on sale
2025-02-18	BUY	115	128.090	130.148	129.942	USD 14,943	101.08
2025-02-13	BUY	23	131.680	132.135	132.089	USD 3,038	99.26
2025-02-12	BUY	23	131.550	133.100	132.945	USD 3,058	98.60
2025-02-11	BUY	69	132.200	134.185	133.986	USD 9,245	97.90
2025-02-06	BUY	207	109.500	114.061	113.605	USD 23,516	96.82
2025-01-27	BUY	23	102.690	105.638	105.343	USD 2,423	94.52
2024-12-30	BUY	115	84.780	84.980	84.960	USD 9,770	94.48
2024-12-06	BUY	92	100.100	100.240	100.226	USD 9,221	93.98
2024-12-05	BUY	23	98.350	99.495	99.381	USD 2,286	93.83
2024-12-04	BUY	115	99.540	102.420	102.132	USD 11,745	93.62
2024-11-29	BUY	115	98.220	100.990	100.713	USD 11,582	92.95
2024-11-27	BUY	92	99.650	100.480	100.397	USD 9,237	92.36
2024-11-26	BUY	23	97.030	99.000	98.803	USD 2,272	92.15
2024-11-21	BUY	115	98.190	99.350	99.234	USD 11,412	91.21
2024-11-20	BUY	69	94.600	96.920	96.688	USD 6,671	91.02
2024-11-18	BUY	276	92.450	95.000	94.745	USD 26,150	90.65
2024-11-12	BUY	184	99.490	101.505	101.303	USD 18,640	90.06
2024-11-08	BUY	115	90.070	91.370	91.240	USD 10,493	90.06
2024-11-07	BUY	345	90.700	92.549	92.364	USD 31,866	90.01
2024-11-06	BUY	46	90.970	93.000	92.797	USD 4,269	89.93
2024-10-31	BUY	23	89.030	90.200	90.083	USD 2,072	90.60

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AXSM

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	68,445	300	138,492	49.4%
2025-09-18	68,724	0	169,529	40.5%
2025-09-17	76,197	40	235,412	32.4%
2025-09-16	165,940	84	332,172	50.0%
2025-09-15	92,091	46	186,500	49.4%
2025-09-12	170,518	1,480	325,952	52.3%
2025-09-11	88,854	16	216,018	41.1%
2025-09-10	61,160	0	187,155	32.7%
2025-09-09	142,408	200	299,185	47.6%
2025-09-08	144,320	0	285,049	50.6%
2025-09-05	104,449	0	205,294	50.9%
2025-09-04	73,216	1,801	138,763	52.8%
2025-09-03	141,477	0	223,165	63.4%
2025-09-02	170,723	300	297,328	57.4%
2025-08-29	64,424	1,970	131,926	48.8%
2025-08-28	55,224	200	123,399	44.8%
2025-08-27	111,321	12	228,559	48.7%
2025-08-26	116,205	0	242,941	47.8%
2025-08-25	54,093	584	115,267	46.9%
2025-08-22	125,994	0	268,008	47.0%
2025-08-21	93,981	600	186,202	50.5%
2025-08-20	105,544	0	162,402	65.0%
2025-08-19	146,328	0	321,780	45.5%
2025-08-18	110,411	0	419,410	26.3%
2025-08-15	58,491	0	149,199	39.2%
2025-08-14	63,117	0	124,653	50.6%
2025-08-13	90,090	0	217,540	41.4%
2025-08-12	50,283	920	155,222	32.4%
2025-08-11	47,068	0	126,857	37.1%
2025-08-08	46,479	0	126,179	36.8%
2025-08-07	65,399	0	143,983	45.4%
2025-08-06	121,354	0	208,439	58.2%
2025-08-05	216,252	15	377,690	57.3%
2025-08-04	274,153	551	441,196	62.1%
2025-08-01	224,315	1,925	341,203	65.7%
2025-07-31	160,824	0	273,054	58.9%
2025-07-30	142,247	9	235,179	60.5%
2025-07-29	117,550	0	233,072	50.4%
2025-07-28	203,714	708	330,365	61.7%
2025-07-25	240,457	35	377,498	63.7%
2025-07-24	112,006	5	181,155	61.8%
2025-07-23	246,830	0	323,571	76.3%
2025-07-22	354,999	0	495,589	71.6%
2025-07-21	126,659	0	205,641	61.6%
2025-07-18	130,794	15	199,458	65.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE